ATE233554T1 - Produkte zur behandlung von glaukoma - Google Patents

Produkte zur behandlung von glaukoma

Info

Publication number
ATE233554T1
ATE233554T1 AT92908766T AT92908766T ATE233554T1 AT E233554 T1 ATE233554 T1 AT E233554T1 AT 92908766 T AT92908766 T AT 92908766T AT 92908766 T AT92908766 T AT 92908766T AT E233554 T1 ATE233554 T1 AT E233554T1
Authority
AT
Austria
Prior art keywords
molecules
glaucoma
masking agents
treatment
products
Prior art date
Application number
AT92908766T
Other languages
English (en)
Inventor
David L Epstein
Original Assignee
Massachusetts Eye & Ear Infirm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Eye & Ear Infirm filed Critical Massachusetts Eye & Ear Infirm
Application granted granted Critical
Publication of ATE233554T1 publication Critical patent/ATE233554T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Treatment And Processing Of Natural Fur Or Leather (AREA)
  • Medicines Containing Plant Substances (AREA)
AT92908766T 1991-03-14 1992-03-16 Produkte zur behandlung von glaukoma ATE233554T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/669,381 US5306731A (en) 1985-06-14 1991-03-14 Method and products for treating the eye
PCT/US1992/002061 WO1992016199A1 (en) 1991-03-14 1992-03-16 Method and products for treating the eye

Publications (1)

Publication Number Publication Date
ATE233554T1 true ATE233554T1 (de) 2003-03-15

Family

ID=24686133

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92908766T ATE233554T1 (de) 1991-03-14 1992-03-16 Produkte zur behandlung von glaukoma

Country Status (10)

Country Link
US (1) US5306731A (de)
EP (1) EP0575524B1 (de)
JP (1) JPH06508607A (de)
AT (1) ATE233554T1 (de)
AU (1) AU665756B2 (de)
CA (1) CA2104868C (de)
DE (1) DE69232942T2 (de)
HU (1) HU221846B1 (de)
IE (1) IE920817A1 (de)
WO (2) WO1992016198A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506226A (en) * 1993-04-19 1996-04-09 Alcon Laboratories, Inc. Ethacrynic acid-like compounds and use thereof to treat glaucoma
SE9303627D0 (sv) * 1993-11-03 1993-11-03 Kabi Pharmacia Ab Method and means for prevention of cataract
US5458883A (en) * 1994-01-12 1995-10-17 Duke University Method of treating disorders of the eye
WO1995033456A2 (en) * 1994-06-07 1995-12-14 Telor Ophthalmic Pharmaceuticals, Inc. Reducing intraocular pressure using aryloxy- and aryl-acetic acids
US5798380A (en) * 1996-02-21 1998-08-25 Wisconsin Alumni Research Foundation Cytoskeletal active agents for glaucoma therapy
US6586425B2 (en) 1996-02-21 2003-07-01 Wisconsin Alumni Research Foundation Cytoskeletal active agents for glaucoma therapy
US5565434A (en) * 1996-02-23 1996-10-15 University Of Iowa Research Foundation Hexose and pentose prodrugs of ethacrynic acid
US5654335A (en) * 1996-02-23 1997-08-05 University Of Iowa Research Foundation Topical use of ethyl ethacrynate for glaucoma treatment
US6573299B1 (en) 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
US8993627B2 (en) * 2005-04-21 2015-03-31 Sentient Lifesciences, Inc. N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
US20090304719A1 (en) 2007-08-22 2009-12-10 Patrick Daugherty Activatable binding polypeptides and methods of identification and use thereof
US20100189727A1 (en) * 2008-12-08 2010-07-29 Tegopharm Corporation Masking Ligands For Reversible Inhibition Of Multivalent Compounds
WO2010081173A2 (en) * 2009-01-12 2010-07-15 Cytomx Therapeutics, Llc Modified antibody compositions, methods of making and using thereof
US8399219B2 (en) 2009-02-23 2013-03-19 Cytomx Therapeutics, Inc. Protease activatable interferon alpha proprotein

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA883792A (en) * 1971-10-19 C. Mezey Kalman Ethacrynic acid suppositories
GB1141422A (en) * 1967-01-27 1969-01-29 Merck & Co Inc Diuretics
US4590210A (en) * 1979-03-09 1986-05-20 Langham Maurice E Compositions for treatment of ocular hypertension
US4596771A (en) * 1982-09-27 1986-06-24 Research Corporation Monoclonal antibodies to vitamin B-6 and immunossay method
US4777130A (en) * 1984-12-05 1988-10-11 Andra Biologicals Isolation of mycobacterial a 60 antigen for diagnostic purposes
WO1986007259A1 (en) * 1985-06-14 1986-12-18 Massachusetts Eye & Ear Infirmary Increasing aqueous humor outflow
JPH0696521B2 (ja) * 1986-01-31 1994-11-30 千寿製薬株式会社 眼局所投与用眼圧降下剤
US4891324A (en) * 1987-01-07 1990-01-02 Syntex (U.S.A.) Inc. Particle with luminescer for assays
US4829011A (en) * 1987-08-27 1989-05-09 Biotrack, Inc. Agglutination assay
US4847209A (en) * 1987-11-09 1989-07-11 Miles Inc. Latex agglutination immunoassay in the presence of hemoglobin

Also Published As

Publication number Publication date
WO1992016198A2 (en) 1992-10-01
AU665756B2 (en) 1996-01-18
HU9302590D0 (en) 1993-12-28
EP0575524B1 (de) 2003-03-05
WO1992016199A1 (en) 1992-10-01
CA2104868A1 (en) 1992-09-15
DE69232942T2 (de) 2003-12-24
US5306731A (en) 1994-04-26
IE920817A1 (en) 1992-09-23
EP0575524A1 (de) 1993-12-29
HU221846B1 (hu) 2003-02-28
DE69232942D1 (de) 2003-04-10
AU1578392A (en) 1992-10-21
HUT64841A (en) 1994-03-28
CA2104868C (en) 2003-02-25
JPH06508607A (ja) 1994-09-29
WO1992016198A3 (en) 1992-11-26

Similar Documents

Publication Publication Date Title
DE69232942D1 (de) Produkte zur behandlung von glaukoma
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
PT868186E (pt) Utilizacao de certos compostos de isoquinolinossulfonilo para tratamento de glaucoma e isquemia ocular
NL970039I2 (nl) Prostaglandinederivaten voor de behandeling van glaucoma of oculaire hypertensie.
BR9611748A (pt) Uso de um produto protéico de fator neurotrófico derivado de linhagem de célula glial
PT671910E (pt) Utilizacao de derivados de adamantano no fabrico de um medicamento para o tratamento do glaucoma
ATE413192T1 (de) Die vorbeugung und behandlung von netzhautischämie und ödem
ATE191143T1 (de) Verwendung von nichtsteroidalen cyclooxygenasehemmern zur herstellung eines medikaments zur behandlung vom erhoehten augeninnendruck
ATE225658T1 (de) Verfahren zur senkung des intrakulären druckes im auge von säugern unter anwendung von kaliumkanalblokker
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
ATE245452T1 (de) Hyaluronatlyase als penetrationsförderer in topischen mitteln
EP1110554A4 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
DE3872701D1 (de) Prostaglandin-derivate zur behandlung von glaucoma oder augenueberdruck.
DE69534620D1 (de) Verfahren zur behandlung von augenerkrankungen
ATE216889T1 (de) Anwendung von prostagrandin-analogen für die behandlung von glaukome und okuläre hypertension
DE60138385D1 (de) Heilmittel zur behandlung von erkrankungen des sehnervs
ATE359774T1 (de) Taurinderivate verwendbar in der behandlung von netzhauterkrankungen
KR930702015A (ko) 각막 장해 치료제
BR0109192A (pt) Tratamento de hipertensão ocular e glaucoma.
ATE320263T1 (de) Verwendung von menschliche protein c zur herstellung eines arzneimittels zur behandlung von heparininduzierter thrombozytopenie
ATE89726T1 (de) Erhoehung des ausfliessens waessriger koerperfluessigkeit.
WO1998014445A3 (en) Novel 6 or 7 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
O'Rourke APR 22TI
BR0015486A (pt) Ligandos de neurofilina para tratamento de condições oculares
RU97103803A (ru) Способ лечения неоваскуляризации роговицы

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties